Research, Development, And Testing Services - Insider Trading Data

Insiders are officers, directors, or significant investors. This page shows insider sentiment and transactions for the Research, industry. Research shows that insider trades are predictive of future stock returns. By examining insider trades for an industry, we can understand what well-informed people think of the overall future industry prospects.

Research, Development, And Testing Services - Insider Buy/Sell Ratio

Insider selling and buying is a useful indicator for analyzing the market because it serves as a proxy for their optimism or pessimism in their own companies. By looking at ratio of total selling and buying across the entire market, we might be able to draw some conclusions about the future market.

We offer two charts here. The first one shows the total dollar volume of buying and selling by insiders. The second chart shows the ratio of the number of insiders selling, vs. the number of insiders buying. In both charts, we filter out trades made by indirect holders (such as trusts), and 10% owners (who, although considered an 'insider' by the SEC, do not actually manage the companies in which they are considered insiders).

Corporate Insider Buy Sell Ratio (Dollar Volume) - Research, Development, And Testing Services
Corporate Insider Buy Sell Ratio (Insider Count) - Research, Development, And Testing Services
Research, Development, And Testing Services - Transaction History

Click the link icon to see the full transaction history. Transactions reported as part of a 10b5-1 automatic trading plan will have an X in the column marked 10b-5.

Tran
Date
Security Form Insider Code 10b5-1 Direct Share
Price
Shares
Changed
2025-01-21 OABI / OmniAb, Inc. 4 Berkman Charles S S - Sale D 3.24 -25,489
2025-01-21 OABI / OmniAb, Inc. 4 GUSTAFSON KURT A S - Sale D 3.24 -15,526
2025-01-21 INCY / Incyte Corporation 4 Stein Steven H S - Sale D 72.69 -12,352
2025-01-21 INCY / Incyte Corporation 4 Morrissey Michael James F - Taxes D 73.47 -429
2025-01-17 OABI / OmniAb, Inc. 4 GUSTAFSON KURT A A - Award D 27,585
2025-01-17 OABI / OmniAb, Inc. 4 Berkman Charles S A - Award D 45,294
2025-01-17 OABI / OmniAb, Inc. 4 FOEHR MATTHEW W A - Award D 77,003
2025-01-15 INCY / Incyte Corporation 4 Morrissey Michael James F - Taxes D 72.46 -908
2025-01-15 INCY / Incyte Corporation 4 Flannelly Barry P F - Taxes D 72.46 -3,158
2025-01-15 INCY / Incyte Corporation 4 Stein Steven H F - Taxes D 72.46 -10,692
2025-01-15 INCY / Incyte Corporation 4 Stamoulis Christiana F - Taxes D 72.46 -3,672
2025-01-13 MXCT / MaxCyte, Inc. 4 Sandoval David I. S - Sale D 4.5391 -4,466
2025-01-10 BIAF / bioAffinity Technologies, Inc. 4 Zannes Maria A - Award D 37,037
2025-01-10 BIAF / bioAffinity Technologies, Inc. 4 GIRGENTI STEVEN A - Award D 14,814
2025-01-10 BIAF / bioAffinity Technologies, Inc. 4 Edwards James Michael A - Award D 6,172
2025-01-10 BIAF / bioAffinity Technologies, Inc. 4 Zannes Timothy P A - Award D 8,641
2025-01-10 BIAF / bioAffinity Technologies, Inc. 4 Reveles Xavier Trinidad A - Award D 21,604
2025-01-06 INCY / Incyte Corporation 4 Issa Mohamed Khairie A - Award D 48,671
2025-01-02 LUNA / Luna Innovations Incorporated 4 ANDERSON N LEIGH M - Exercise D 2,850
2025-01-02 LUNA / Luna Innovations Incorporated 4 ANDERSON N LEIGH M - Exercise D 11,819
2025-01-02 LUNA / Luna Innovations Incorporated 4 SPIEGEL GARY M - Exercise D 1,139
2025-01-02 LUNA / Luna Innovations Incorporated 4 ANDERSON N LEIGH M - Exercise D 1,344
2025-01-02 LUNA / Luna Innovations Incorporated 4 SPIEGEL GARY M - Exercise D 7,102
2025-01-02 NRC / NRC Health 4 Hays Michael D. M - Exercise D 13.17 10,014
2025-01-02 LUNA / Luna Innovations Incorporated 4 SPIEGEL GARY M - Exercise D 946
2025-01-02 LUNA / Luna Innovations Incorporated 4 SPIEGEL GARY M - Exercise D 745
2025-01-02 LUNA / Luna Innovations Incorporated 4 SPIEGEL GARY M - Exercise D 740
2025-01-02 LUNA / Luna Innovations Incorporated 4 ANDERSON N LEIGH M - Exercise D 1,518
2025-01-02 LUNA / Luna Innovations Incorporated 4 ANDERSON N LEIGH M - Exercise D 2,338
2025-01-01 NEO / NeoGenomics, Inc. 4 Harris Melody F - Taxes D -7,070
2025-01-01 ONMD / OneMedNet Corporation 4 Zeinfeld Andrew B A - Award D 82,143
2025-01-01 ONMD / OneMedNet Corporation 4 Clarke Jair A - Award D 82,143
2024-12-31 MEDP / Medpace Holdings, Inc. 4 Kraft Robert O. M - Exercise D 71
2024-12-31 MEDP / Medpace Holdings, Inc. 4 McCarthy Cornelius P. III M - Exercise D 62
2024-12-31 MEDP / Medpace Holdings, Inc. 4 Carley Brian T M - Exercise D 78
2024-12-31 NRC / NRC Health 4 Amandla MK Trust By Amandla, LLC G - Gift I -4,755,317
2024-12-31 NRC / NRC Health 4 Common Property Trust By Amandla, LLC G - Gift I 4,755,317
2024-12-31 INCY / Incyte Corporation 4 HARRIGAN EDMUND A - Award D 69.07 339
2024-12-31 INCY / Incyte Corporation 4 Clancy Paul J A - Award D 69.07 331
2024-12-31 INCY / Incyte Corporation 4 BAKER BROS. ADVISORS LP See Footnotes A - Award I 446
2024-12-31 INCY / Incyte Corporation 4 BAKER BROS. ADVISORS LP See Footnotes A - Award I 446
2024-12-26 MXCT / MaxCyte, Inc. 4 Johnston John Joseph S - Sale D 4.007 -3,000
2024-12-26 MXCT / MaxCyte, Inc. 4 Johnston John Joseph M - Exercise D 2.932 3,000
2024-12-20 LUNA / Luna Innovations Incorporated 4 Coe Pamela L M - Exercise D 13,372
2024-12-19 NOTV / Inotiv, Inc. 4 Landman David P - Purchase D 4.25 23,529
2024-12-18 ONMD / OneMedNet Corporation 4 Yu Jeffrey P - Purchase D 0.99 100
2024-12-16 INCY / Incyte Corporation 4 Tray Thomas S - Sale D 69.31 -650
2024-12-13 INCY / Incyte Corporation 4 Tray Thomas S - Sale D 70.64 -650
2024-12-10 NOTV / Inotiv, Inc. 4 Beattie John Gregory P - Purchase D 4.75 30,000
2024-12-10 NOTV / Inotiv, Inc. 4 Brown Nigel P - Purchase D 4.26 7,500
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)